Chapter 22 Structure, Function, and Regulation of Insulin-Degrading Enzyme

Vitamins and Hormones

Volumn 80, Issue C, 2009, Pages 635-648

  Hulse, Raymond E ^a   Ralat, Luis A ^b   Wei Jen, Tang ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Insulin; Insulin degrading enzyme; Metalloprotease; X ray crystallography

Indexed keywords

INSULIN; INSULINASE;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; PROTEIN CONFORMATION; RAT;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INSULIN; INSULYSIN; MICE; MODELS, MOLECULAR; PROTEIN CONFORMATION; RATS;

EID: 61349113484     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)00622-5     Document Type: Review

References (49)

1. Authier F., Bergeron J., Ou W., Rachubinski R., Posner B., and Walton P. Degradation of the cleaved leader peptide f thiolase by a peroxisomal proteinase. Proc. Natl. Acad. Sci. 92 (1995) 5
2. Authier F., Cameron P.H., and Taupin V. Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells. Biochem. J. 319 Pt. 1 (1996) 149-158
3. Authier F., Metioui M., Fabrega S., Kouach M., and Briand G. Endosomal proteolysis of internalized insulin at the C-terminal region of the B chain by cathepsin D. J. Biol. Chem. 277 (2002) 9437-9446
4. Bennett R.G., Duckworth W.C., and Hamel F.G. Degradation of amylin by insulin-degrading enzyme. J. Biol. Chem. 275 (2000) 36621-36625
5. Bondy C.A., Zhou J., Chin E., Reinhardt R.R., Ding L., and Roth R.A. Cellular distribution of insulin-degrading enzyme gene expression. Comparison with insulin and insulin-like growth factor receptors. J. Clin. Invest. 93 (1994) 966-973
6. Camberos M.C., Perez A.A., Udrisar D.P., Wanderley M.I., and Cresto J.C. ATP inhibits insulin-degrading enzyme activity. Exp. Biol. Med. (Maywood) 226 (2001) 334-341
7. Chesneau V., and Rosner M. Functional human insulin-degrading enzyme can be expressed in bacteria. Protein Expr. Purif. 19 (2000) 91-98
8. Duckworth W.C., Bennett R.G., and Hamel F.G. Insulin degradation: Progress and potential. Endocr. Rev. 19 (1998) 608-624
9. Duckworth W.C., and Kitabchi A.E. Insulin and glucagon degradation by the same enzyme. Diabetes 23 (1974) 536-543
10. Fakhrai-Rad H., Nikoshkov A., Kamel A., Fernström M., Zierath J.R., Norgren S., Luthman H., and Galli J. Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. Hum. Mol. Genet. 9 (2000) 2149-2158
11. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E.A., Frosch M.P., Eckman C.B., Tanzi R.E., Selkoe D., and Guenette S. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. USA 100 (2003) 4162-4167
12. Fawcett J., Permana P.A., Levy J.L., and Duckworth W.C. Regulation of protein degradation by insulin-degrading enzyme: Analysis by small interfering RNA-mediated gene silencing. Arch. Biochem. Biophys. 468 (2007) 128-133
13. Florez J.C., Wiltshire S., Agapakis C.M., Burtt N.P., de Bakker P.I., Almgren P., Bengtsson Boström K., Tuomi T., Gaudet D., Daly M.J., Hirschhorn J.N., McCarthy M.I., et al. High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people. Diabetes 55 (2006) 128-135
14. Grasso G., Rizzarelli E., and Spoto G. AP/MALDI-MS complete characterization of the proteolytic fragments produced by the interaction of insulin degrading enzyme with bovine insulin. J. Mass Spectrom. 42 (2007) 1590-1598
15. Groves C.J., Wiltshire S., Smedley D., Owen K.R., Frayling T.M., Walker M., Hitman G.A., Levy J.C., O'Rahilly S., Menzel S., Hattersley A.T., and McCarthy M.I. Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. Diabetes 52 (2003) 1300-1305
16. Gu H.F., Efendic S., Nordman S., Ostenson C.G., Brismar K., Brookes A.J., and Prince J.A. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels. Diabetes 53 (2004) 2137-2142
17. Hamel F.G., Upward J.L., and Bennett R.G. In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme A thioesters. Endocrinology 144 (2003) 2404-2408
18. Hari J., Shii K., and Roth R.A. In vivo association of [125I]-insulin with a cytosolic insulin-degrading enzyme: Detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody. Endocrinology 120 (1987) 829-831
19. Hersh L. The insulysin (insulin degrading enzyme) enigma. Cell. Mol. Life Sci. 63 (2006) 2432-2434
20. Im H., Manolopoulou M., Malito E., Shen Y., Zhao J., Neant-Fery M., Sun C., Meredith S., Sisodia S., Leissring M., and Tang W. Structure of substrate-free human insulin-degrading enzyme (IDE) and Biophysical analysis of ATP-induced conformational switch of IDE. J. Biol. Chem. 282 (2007) 25453-25463
21. Jee S., Hwang D., Seo S., Kim Y., Kim C., Kim B., Shim S., Lee S., Sin J., Bae C., Lee B., Jang M., et al. Microarray analysis of insulin-regulated gene expression in the liver: The use of transgenic mice co-expressing insulin-siRNA and human IDE as an animal model. Int. J. Mol. Med. 20 (2007) 829-835
22. Johnson K., Bhushan S., Ståhl A., Hallberg B., Frohn A., Glaser E., and Eneqvist T. The closed structure of presequence protease PreP forms a unique 10 000 Å3 chamber for proteolysis. EMBO J. 25 (2006) 1977-1986
23. Karamohamed S., Demissie S., Volcjak J., Liu C., Heard-Costa N., Liu J., Shoemaker C.M., Panhuysen C.I., Meigs J.B., Wilson P., Atwood L.D., Cupples L.A., et al. Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham heart study. Diabetes 52 (2003) 1562-1567
24. Kuo W.L., Gehm B.D., and Rosner M.R. Regulation of insulin degradation: Expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway. Mol. Endocrinol. 5 (1991) 1467-1476
25. Kurochkin I.V. Insulin-degrading enzyme: Embarking on amyloid destruction. Trends Biochem. Sci. 26 (2001) 421-425
26. Leissring M.A., Farris W., Wu X., Christodoulou D.C., Haigis M.C., Guarente L., and Selkoe D.J. Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria. Biochem. J. 383 (2004) 439-446
27. Li P., Kuo W.L., Yousef M., Rosner M.R., and Tang W. The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition. Biochem. and Biophys. Res. Commun. 343 (2006) 1032-1037
28. Malito E., Hulse R.E., and Tang W.J. Amyloid β-degrading cryptidases: Insulin degrading enzyme, presequence peptidase, and neprilysin. Cell. Mol. Life Sci. 65 (2008) 2574-2585
29. Malito E., Ralat L.A., Manolopoulou M., Tsay J.L., Wadlington N.L., and Tang W.J. Molecular bases for the recognition of the short peptide substrate and cysteine-directed modifications of human insulin-degrading enzyme. Biochemistry 47 (2008) 12822-12834
30. Marlowe L., Peila R., Benke K.S., Hardy J., White L.R., Launer L.J., and Myers A. Insulin-degrading enzyme haplotypes affect insulin levels but not dementia risk. Neurodegener Dis. 3 (2006) 320-326
31. Maskos K. Handbook of Metalloproteins (2004), Wiley, New York
32. Melino G., Draoui M., Bernardini S., Bellincampi L., Reichert U., and Cohen P. Regulation by retinoic acid of insulin-degrading enzyme and of a related endoprotease in human neuroblastoma cell lines. Cell Growth Differ. 7 (1996) 787-796
33. Mentlein R., Ludwig R., and Martensen I. Proteolytic degradation of Alzheimer's disease amyloid beta-peptide by a metalloproteinase from microglia cells. J. Neurochem. 70 (1998) 721-726
34. Mirsky I.A., and Broh-kahn R.H. The inactivation of insulin by tissue extracts; the distribution and properties of insulin inactivating extracts. Arch. Biochem. 20 (1949) 1-9
35. Mirsky I.A., Simkin B., and Broh-Kahn R.H. The inactivation of insulin by tissue extracts. VI. The existence, distribution and properties of an insulinase inhibitor. Arch. Biochem. 28 (1950) 415-423
36. Perlman R.K., Gehm B.D., Kuo W.L., and Rosner M.R. Functional analysis of conserved residues in the active site of insulin-degrading enzyme. J. Biol. Chem. 268 (1993) 21538-21544
37. Qiu W.Q., and Folstein M.F. Insulin, insulin-degrading enzyme, and amyloid-beta peptide in Alzheimer's disease: Review and hypothesis. Neurobiol. Aging 27 (2006) 190-198
38. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., Rosner M.R., Safavi A., Hersh L.B., and Selkoe D.J. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem. 273 (1998) 32730-32738
39. Ryan M.P., Gifford J.D., Solomon S.S., and Duckworth W.C. The calcium dependence of insulin degradation by rat skeletal muscle. Endocrinology 117 (1985) 1693-1698
40. Shen Y., Joachimiak A., Rich Rosner M., and Tang W. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 443 (2006) 870-874
41. Shii K., and Roth R.A. Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. Proc. Natl. Acad. Sci. USA 83 (1986) 4147-4151
42. Shinall H., Song E.S., and Hersh L.B. Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: A potential Alzheimer's disease spiral. Biochemistry 44 (2005) 15345-15350
43. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., Balkau B., Heude B., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
44. Song E.S., Juliano M.A., Juliano L., and Hersh L.B. Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development. J. Biol. Chem. 278 (2003) 49789-49794
45. Song E.S., Juliano M.A., Juliano L., Fried M.G., Wagner S.L., and Hersh L.B. ATP effects on insulin-degrading enzyme are mediated primarily through its triphosphate moiety. J. Biol. Chem. 279 (2004) 54216-54220
46. Stocker R., and Keaney J.F.Jr. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84 (2004) 1381-1478
47. Sudoh S., Frosch M.P., and Wolf B. Differential effects of protease involved in intracellular degradation of amyloid-beta protein between detergent soluble and insolube pools in CHO-695 cells. Biochemistry 41 (2002) 9
48. Vekrellis K., Ye Z., Qiu W.Q., Walsh D., Hartley D., Chesneau V., Rosner M.R., and Selkoe D.J. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J. Neurosci. 20 (2000) 1657-1665
49. Zhao L., Teter B., Morihara T., Lim G.P., Ambegaokar S.S., Ubeda O.J., Frautschy S.A., and Cole G.M. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: Implications for Alzheimer's disease intervention. J. Neurosci. 24 (2004) 11120-11126